Shanghai Henlius Biotech Inc Sustainability Reports
The company is a global biopharmaceutical platform specializing in developing, manufacturing, and commercializing high-quality, affordable protein therapeutics, including monoclonal antibody biosimilars and innovative novel biologics.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
LEI: 836800ZRCDRCBVC47C57
FIGI: BBG00PNKW4M6
14 reports from 2019 to 2025